ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

ResMed (NYSE: RMD, ASX: RMD) has announced that Chairman and CEO Mick Farrell and Chief Medical Officer Dr. Carlos Nunez will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for Wednesday, September 4, 2024, at approximately 10:00 a.m. EDT at the New York Marriott Marquis.

Investors and interested parties can access the live, audio-only webcast through ResMed's investor relations website. A replay of the webcast will be available for 30 days following the event, accessible approximately 24 hours after the live session ends.

News Market Reaction – RMD

+0.19%

+0.19% Session move

In the trading session that priced this news, RMD gained 0.19%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, beginning at approximately 10:00 a.m. (Eastern Daylight Time) at the New York Marriott Marquis in New York, NY.

More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors	For media
+1 858.836.5000	+1 619.510.1281
investorrelations@resmed.com	news@resmed.com

                                

 

FAQ

When and where is ResMed (RMD) participating in the Morgan Stanley Global Healthcare Conference?

ResMed (RMD) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at approximately 10:00 a.m. EDT at the New York Marriott Marquis in New York, NY.

Who will represent ResMed (RMD) at the Morgan Stanley healthcare conference?

Mick Farrell, Chairman and CEO, and Dr. Carlos Nunez, Chief Medical Officer, will represent ResMed (RMD) at the Morgan Stanley healthcare conference.

How can investors access ResMed's (RMD) presentation at the Morgan Stanley conference?

Investors can access the live, audio-only webcast of ResMed's (RMD) presentation by visiting https://investor.resmed.com. A replay will be available for 30 days after the event.